Cozadd Bruce C.'s most recent trade in Jazz Pharmaceuticals plc was a trade of 1,000 Ordinary Shares done at an average price of $113.2 . Disclosure was reported to the exchange on Aug. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 113.21 per share. | 01 Aug 2025 | 1,000 | 435,973 (0%) | 0% | 113.2 | 113,210 | Ordinary Shares |
| Jazz Pharmaceuticals plc | C. Bruce Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 01 Jul 2025 | 500 | 436,973 (0%) | 0% | 110 | 55,000 | Ordinary Shares |
| Jazz Pharmaceuticals plc | C. Bruce Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 105.26 per share. | 01 Jul 2025 | 500 | 437,473 (0%) | 0% | 105.3 | 52,630 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 02 Jun 2025 | 500 | 437,973 (0%) | 0% | 110 | 55,000 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 107.90 per share. | 02 Jun 2025 | 500 | 438,473 (0%) | 0% | 107.9 | 53,950 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 116.35 per share. | 01 May 2025 | 1,000 | 439,307 (0%) | 0% | 116.4 | 116,350 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 01 May 2025 | 500 | 438,807 (0%) | 0% | 120 | 60,000 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 123.75 per share. | 01 Apr 2025 | 1,500 | 440,307 (0%) | 0% | 123.8 | 185,625 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale or transfer of securities back to the company at price $ 138.95 per share. | 05 Mar 2025 | 22,251 | 441,807 (0%) | 0% | 138.9 | 3,091,776 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 30,814 | 470,558 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 144.25 per share. | 27 Feb 2025 | 6,500 | 464,058 (0%) | 0% | 144.3 | 937,625 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 122.31 per share. | 03 Feb 2025 | 1,500 | 439,744 (0%) | 0% | 122.3 | 183,465 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 29,559 | 455,084 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.62 per share. | 17 Jan 2025 | 13,840 | 441,244 (0%) | 0% | 122.6 | 1,697,061 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 123.43 per share. | 02 Jan 2025 | 1,500 | 425,525 (0%) | 0% | 123.4 | 185,145 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 121.17 per share. | 02 Dec 2024 | 2,000 | 427,025 (0%) | 0% | 121.2 | 242,340 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 110.84 per share. | 01 Nov 2024 | 1,000 | 428,976 (0%) | 0% | 110.8 | 110,840 | Ordinary Shares |
| Acelyrin Inc | Bruce C. Cozadd | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 92,158 | 92,158 | - | - | Director Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.53 per share. | 05 Mar 2024 | 22,436 | 429,809 (0%) | 0% | 117.5 | 2,636,903 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 50,187 | 452,245 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Cozadd Bruce C. | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 26,545 | 414,303 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Cozadd Bruce C. | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 119.13 per share. | 17 Jan 2024 | 12,245 | 402,058 (0%) | 0% | 119.1 | 1,458,747 | Ordinary Shares |
| Acelyrin Inc | Bruce C. Cozadd | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 183,434 | 0 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Bruce C. Cozadd | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 183,434 | 183,434 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Bruce C. Cozadd | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 23,243 | 0 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Bruce C. Cozadd | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 23,243 | 23,243 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Bruce C. Cozadd | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 23,243 | 23,243 | - | - | Director Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 42,388 | 409,466 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.78 per share. | 03 Mar 2023 | 21,882 | 387,584 (0%) | 0% | 142.8 | 3,124,312 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 155.79 per share. | 01 Feb 2023 | 1,000 | 367,078 (0%) | 0% | 155.8 | 155,790 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 03 Jan 2023 | 2,000 | 368,078 (0%) | 0% | 160 | 320,000 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 159.59 per share. | 03 Jan 2023 | 1,000 | 370,078 (0%) | 0% | 159.6 | 159,590 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 157.00 per share. | 01 Dec 2022 | 1,000 | 371,078 (0%) | 0% | 157 | 157,000 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 10 Nov 2022 | 2,000 | 372,028 (0%) | 0% | 150 | 300,000 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 62,905 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.13 per share. | 03 Oct 2022 | 62,905 | 419,213 (0%) | 0% | 59.1 | 3,719,573 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 135.18 per share. | 03 Oct 2022 | 23,646 | 381,776 (0%) | 0% | 135.2 | 3,196,386 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 134.02 per share. | 03 Oct 2022 | 13,791 | 405,422 (0%) | 0% | 134.0 | 1,848,307 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 135.80 per share. | 03 Oct 2022 | 7,748 | 374,028 (0%) | 0% | 135.8 | 1,052,213 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2022 | 9,700 | 62,905 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.13 per share. | 06 Sep 2022 | 9,700 | 363,011 (0%) | 0% | 59.1 | 573,561 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 152.41 per share. | 06 Sep 2022 | 4,517 | 358,494 (0%) | 0% | 152.4 | 688,436 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 153.13 per share. | 06 Sep 2022 | 1,170 | 357,324 (0%) | 0% | 153.1 | 179,162 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 155.10 per share. | 06 Sep 2022 | 1,000 | 353,311 (0%) | 0% | 155.1 | 155,100 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 155.22 per share. | 06 Sep 2022 | 542 | 356,308 (0%) | 0% | 155.2 | 84,129 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 154.31 per share. | 06 Sep 2022 | 474 | 356,850 (0%) | 0% | 154.3 | 73,143 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 9,632 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.83 per share. | 01 Aug 2022 | 9,632 | 361,544 (0%) | 0% | 46.8 | 451,067 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 154.50 per share. | 01 Aug 2022 | 2,601 | 356,411 (0%) | 0% | 154.5 | 401,858 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 153.48 per share. | 01 Aug 2022 | 2,600 | 359,012 (0%) | 0% | 153.5 | 399,052 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 155.27 per share. | 01 Aug 2022 | 1,100 | 355,311 (0%) | 0% | 155.3 | 170,795 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 154.94 per share. | 01 Aug 2022 | 1,000 | 354,311 (0%) | 0% | 154.9 | 154,940 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.13 per share. | 01 Aug 2022 | 68 | 361,612 (0%) | 0% | 59.1 | 4,021 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 68 | 72,605 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2022 | 9,700 | 9,632 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.83 per share. | 05 Jul 2022 | 9,700 | 360,687 (0%) | 0% | 46.8 | 454,251 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 156.65 per share. | 05 Jul 2022 | 5,839 | 354,848 (0%) | 0% | 156.7 | 914,687 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 05 Jul 2022 | 1,500 | 351,912 (0%) | 0% | 160 | 240,000 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 156.95 per share. | 05 Jul 2022 | 1,000 | 353,412 (0%) | 0% | 157.0 | 156,950 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 157.13 per share. | 05 Jul 2022 | 436 | 354,412 (0%) | 0% | 157.1 | 68,509 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.83 per share. | 01 Jun 2022 | 9,700 | 358,349 (0%) | 0% | 46.8 | 454,251 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 9,700 | 19,332 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 145.42 per share. | 01 Jun 2022 | 2,412 | 355,937 (0%) | 0% | 145.4 | 350,753 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 146.05 per share. | 01 Jun 2022 | 1,360 | 354,577 (0%) | 0% | 146.1 | 198,628 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 148.13 per share. | 01 Jun 2022 | 1,270 | 353,307 (0%) | 0% | 148.1 | 188,125 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 01 Jun 2022 | 1,000 | 350,987 (0%) | 0% | 150 | 150,000 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 148.82 per share. | 01 Jun 2022 | 831 | 352,476 (0%) | 0% | 148.8 | 123,669 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 149.68 per share. | 01 Jun 2022 | 489 | 351,987 (0%) | 0% | 149.7 | 73,194 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.83 per share. | 02 May 2022 | 9,700 | 355,762 (0%) | 0% | 46.8 | 454,251 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2022 | 9,700 | 29,032 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 156.13 per share. | 02 May 2022 | 3,177 | 350,985 (0%) | 0% | 156.1 | 496,025 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 155.34 per share. | 02 May 2022 | 1,600 | 354,162 (0%) | 0% | 155.3 | 248,544 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 158.67 per share. | 02 May 2022 | 1,000 | 348,502 (0%) | 0% | 158.7 | 158,670 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 156.97 per share. | 02 May 2022 | 767 | 350,218 (0%) | 0% | 157.0 | 120,396 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 158.53 per share. | 02 May 2022 | 716 | 349,502 (0%) | 0% | 158.5 | 113,507 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2022 | 9,700 | 38,732 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.83 per share. | 04 Apr 2022 | 9,700 | 356,834 (0%) | 0% | 46.8 | 454,251 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 04 Apr 2022 | 3,500 | 346,062 (0%) | 0% | 160 | 560,000 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 157.49 per share. | 04 Apr 2022 | 3,228 | 351,856 (0%) | 0% | 157.5 | 508,362 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 156.33 per share. | 04 Apr 2022 | 1,750 | 355,084 (0%) | 0% | 156.3 | 273,569 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 158.37 per share. | 04 Apr 2022 | 1,294 | 350,562 (0%) | 0% | 158.4 | 204,934 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 158.64 per share. | 04 Apr 2022 | 1,000 | 349,562 (0%) | 0% | 158.6 | 158,640 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2022 | 1,288 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.13 per share. | 17 Mar 2022 | 1,288 | 347,134 (0%) | 0% | 59.1 | 76,159 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 44,788 | 367,775 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 153.96 per share. | 03 Mar 2022 | 21,929 | 345,846 (0%) | 0% | 154.0 | 3,376,189 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 9,700 | 48,432 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.83 per share. | 01 Mar 2022 | 9,700 | 335,488 (0%) | 0% | 46.8 | 454,251 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 01 Mar 2022 | 6,000 | 322,987 (0%) | 0% | 150 | 900,000 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 135.73 per share. | 01 Mar 2022 | 3,260 | 332,228 (0%) | 0% | 135.7 | 442,486 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 136.73 per share. | 01 Mar 2022 | 3,041 | 329,187 (0%) | 0% | 136.7 | 415,792 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 137.40 per share. | 01 Mar 2022 | 200 | 328,987 (0%) | 0% | 137.4 | 27,481 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 9,700 | 58,132 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.83 per share. | 01 Feb 2022 | 9,700 | 332,160 (0%) | 0% | 46.8 | 454,251 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 140.26 per share. | 01 Feb 2022 | 2,186 | 325,788 (0%) | 0% | 140.3 | 306,618 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 139.24 per share. | 01 Feb 2022 | 2,136 | 327,974 (0%) | 0% | 139.2 | 297,416 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 138.11 per share. | 01 Feb 2022 | 2,050 | 330,110 (0%) | 0% | 138.1 | 283,134 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 9,700 | 67,832 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.83 per share. | 03 Jan 2022 | 9,700 | 328,251 (0%) | 0% | 46.8 | 454,251 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 128.67 per share. | 03 Jan 2022 | 2,651 | 322,600 (0%) | 0% | 128.7 | 341,104 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 126.72 per share. | 03 Jan 2022 | 1,819 | 326,432 (0%) | 0% | 126.7 | 230,504 | Ordinary Shares |